Human Biomed, Inc., funded under Program Announcement #17-09-ECLS, has made great progress toward the advancement of prototype development. The team has recently demonstrated in vivo proof of concept of an extracorporeal life support (ECLS) device to simultaneously replace impaired lung and kidney functions. The principal feature of their system is the use of a multi-functional detoxifying filter (MDF). The MDF is a patented filter apparatus which performs multiple blood purification functions including high volume hemofiltration, blood oxygenation, and CO2 removal. Thus, it effectively supports lung and kidney functions.
These purification methods are all integrated into a single filter unit in the MDF. Their animal work showed that their device was able to consistently oxygenate incoming blood and remove CO2 from incoming blood, and prohibit the advancement of renal dysfunction, inhibiting the increase in uremic toxin concentrations, while providing continuous renal replacement therapy (CRRT). We look forward to hearing about their continued progress.